Mixed
Laparoscopic bariatric surgery (specifically RYGB and SG) produces greater weight loss and higher rates of type 2 diabetes remission compared to non-surgical interventions, including lifestyle changes and GLP-1 receptor agonists.
For severe obesity, laparoscopic surgery (like gastric bypass or sleeve) currently offers the highest chance of significant, sustained weight loss (20-30%) and diabetes remission compared to drugs or diet alone. However, it requires lifelong vitamin supplementation and carries surgical risks. New medications (GLP-1s) are closing the gap, offering 15-20% loss, but surgery remains the most effective option for those who qualify.
Bariatric surgery is an effective treatment for obesity and in general reduces all-cause mortality compared with the comparator group and leads to significant reductions in T2D and hypertension... The most effective treatment for weight loss is bariatric surgery... GLP-1-RA medications... achieving weight losses of 15% to 20% when combined with lifestyle changes... bariatric surgery... leads to a weight loss of 20% to 30% with limited weight regain even after 15 years.
Why this rating
This is a protocol for a systematic review; no primary data or pooled results are presented yet, only references to existing trials.
Source
Laparoscopic bariatric surgery versus any non-surgical intervention for adolescents or adults with obesity: protocol for a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
Olivia Maltha Duun et al. · BMJ Open · 2026
DOI 10.1136/bmjopen-2025-111336
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →